Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany - Baseline characteristics of the POWER@MS1 randomised controlled trial.
Krause N, Derad C, von Glasenapp B, Riemann-Lorenz K, Temmes H, van de Loo M, Friede T, Asendorf T, Heesen C; POWER@MS1 study group. Krause N, et al. Mult Scler Relat Disord. 2023 Nov;79:105043. doi: 10.1016/j.msard.2023.105043. Epub 2023 Oct 5. Mult Scler Relat Disord. 2023. PMID: 37839367 Free article. Clinical Trial.
Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany.
Koppe U, Schilling J, Stecher M, Rüthrich MM, Marquis A, Diercke M, Haselberger M, Koll CEM, Niebank M, Ruehe B, Borgmann S, Grabenhenrich L, Hellwig K, Pilgram L, Spinner CD, Paerisch T; LEOSS study group. Koppe U, et al. Among authors: hellwig k. BMC Infect Dis. 2023 Feb 10;23(1):89. doi: 10.1186/s12879-023-08035-z. BMC Infect Dis. 2023. PMID: 36765274 Free PMC article.
Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry.
Schmidt-Hellerau K, Raichle C, Ruethrich MM, Vehreschild JJ, Lanznaster J, Nunes de Miranda SM, Bausewein C, Vehreschild MJGT, Koll CEM, Simon ST, Hellwig K, Jensen BO, Jung N; LEOSS Study Group. Schmidt-Hellerau K, et al. Among authors: hellwig k. Infection. 2023 Aug;51(4):1119-1126. doi: 10.1007/s15010-023-02020-z. Epub 2023 Mar 23. Infection. 2023. PMID: 36952127 Free PMC article.
Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON).
Appel KS, Nürnberger C, Bahmer T, Förster C, Polidori MC, Kohls M, Kraus T, Hettich-Damm N, Petersen J, Blaschke S, Bröhl I, Butzmann J, Dashti H, Deckert J, Dreher M, Fiedler K, Finke C, Geisler R, Hanses F, Hopff SM, Jensen BO, Konik M, Lehnert K, de Miranda SMN, Mitrov L, Miljukov O, Reese JP, Rohde G, Scherer M, Tausche K, Tebbe JJ, Vehreschild JJ, Voit F, Wagner P, Weigl M, Lemhöfer C; NAPKON Study Group. Appel KS, et al. Infection. 2024 Oct;52(5):1813-1829. doi: 10.1007/s15010-024-02226-9. Epub 2024 Apr 8. Infection. 2024. PMID: 38587752 Free PMC article.
Impact of disease-modifying therapies on pregnancy outcomes in multiple sclerosis: a prospective cohort study from the German multiple sclerosis and pregnancy registry.
Bast N, Dost-Kovalsky K, Haben S, Friedmann N, Witt L, Oganowski T, Gold R, Thiel S, Hellwig K. Bast N, et al. Among authors: hellwig k. Lancet Reg Health Eur. 2024 Dec 2;48:101137. doi: 10.1016/j.lanepe.2024.101137. eCollection 2025 Jan. Lancet Reg Health Eur. 2024. PMID: 39811788 Free PMC article.
Ofatumumab-exposed breastfeeding in multiple sclerosis patients.
Witt L, Dost-Kovalsky K, Friedmann N, Bast N, Haben S, Oganowski T, Gold R, Hellwig K, Thiel S. Witt L, et al. Among authors: hellwig k. Mult Scler. 2025 Jan 6:13524585241307165. doi: 10.1177/13524585241307165. Online ahead of print. Mult Scler. 2025. PMID: 39757874
Diabetes impairs IFNγ-dependent antibacterial defense in the lungs.
Fiocca Vernengo F, Röwekamp I, Boillot L, Caesar S, Dörner PJ, Tarnowski B, Gutbier B, Nouailles G, Fatykhova D, Hellwig K, Witzenrath M, Hocke AC, Klatt AB, Opitz B. Fiocca Vernengo F, et al. Among authors: hellwig k. Mucosal Immunol. 2024 Dec 31:S1933-0219(24)00138-7. doi: 10.1016/j.mucimm.2024.12.015. Online ahead of print. Mucosal Immunol. 2024. PMID: 39746547 Free article.
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD.
Häußler V, Trebst C, Engels D, Pellkofer H, Havla J, Duchow A, Schindler P, Schwake C, Pakeerathan T, Fischer K, Ringelstein M, Lindenblatt G, Hümmert MW, Tkachenko D, Bütow F, Giglhuber K, Flaskamp M, Schiffmann I, Korporal-Kuhnke M, Jarius S, Dawin E, Revie L, Senel M, Herfurth M, Walter A, Pompsch M, Kleiter I, Angstwurm K, Kaste M, Grothe M, Wickel J, Rommer PS, Sieb JP, Krämer M, Then Bergh F, Tumani H, Klotz L, Wildemann B, Aktas O, Ayzenberg I, Bellmann-Strobl J, Paul F, Kümpfel T, Friede T, Berthele A, Stellmann JP; Neuromyelitis optica study group (NEMOS). Häußler V, et al. J Neurol Neurosurg Psychiatry. 2024 Dec 27:jnnp-2024-334764. doi: 10.1136/jnnp-2024-334764. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 39730197 Free article.
Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab.
Vukusic S, Bove R, Dobson R, McElrath T, Oreja-Guevara C, Pietrasanta C, Lin CJ, Ferreira G, Craveiro L, Zecevic D, Pasquarelli N, Hellwig K. Vukusic S, et al. Among authors: hellwig k. Neurol Neuroimmunol Neuroinflamm. 2025 Jan;12(1):e200349. doi: 10.1212/NXI.0000000000200349. Epub 2024 Dec 17. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39689270 Free PMC article.
274 results